Clinical Trials Logo

Gastro Intestinal Stromal Tumour clinical trials

View clinical trials related to Gastro Intestinal Stromal Tumour.

Filter by:
  • None
  • Page 1

NCT ID: NCT04566614 Recruiting - Clinical trials for Biliary Tract Neoplasms

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

PREVAILctDNA
Start date: June 18, 2020
Phase:
Study type: Observational

The purpose of this study is to investigate the feasibility of using ctDNA to support cancer diagnosis and risk stratification where invasive aerosol generating testing (and/or tissue biopsy) is challenging due to infection risk, technical impracticalities and resource limitations, such as during the COVID-19 pandemic and the subsequent recovery period.

NCT ID: NCT04193553 Completed - Clinical trials for Gastro Intestinal Stromal Tumour

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

LENVAGIST
Start date: January 17, 2020
Phase: Phase 2
Study type: Interventional

The primary objective is to compare the efficacy of lenvatinib plus Best Supportive Care versus Placebo plus Best Supportive Care in the treatment of patients with advanced GIST, after failure of imatinib and sunitinib.

NCT ID: NCT02009423 Terminated - Clinical trials for Gastro-Intestinal Stromal Tumour

Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence

Start date: July 2015
Phase: Phase 3
Study type: Interventional

The objective is to compare the efficacy and safety of masitinib at 4.5 mg/kg/day to placebo in the treatment of patients with localized, primary gastrointestinal stromal tumor (GIST) after complete surgery and with high risk of recurrence.